550P Initial results of a phase Ia/Ib study of NGM120, a first-in-class anti-GDNF family receptor alpha like (GFRAL) antibody in patients (pts) with advanced solid tumors.

Autor:	Jain, R.1 (AUTHOR), Kim, E.J.2 (AUTHOR), Lenz, H-J.3 (AUTHOR), Messersmith, W.A.4 (AUTHOR), Picozzi, V.J.5 (AUTHOR), Beg, M.S.6 (AUTHOR), Weinberg, B.A.7 (AUTHOR), Mahalingam, D.8 (AUTHOR), Tran-Muchowski, C.9 (AUTHOR), Yuan, N.9 (AUTHOR), Lichtman, J.10 (AUTHOR), Chen, C.9 (AUTHOR), McDonald, L.9 (AUTHOR), DePaoli, A.10 (AUTHOR), Zha, J.10 (AUTHOR), Hendifar, A.E.11 (AUTHOR)
Zdroj:	Annals of Oncology. 2021 Supplement 5, Vol. 32, pS610-S611. 2p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu